549 related articles for article (PubMed ID: 28691255)
1. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery.
Broglie MA; Stoeckli SJ; Sauter R; Pasche P; Reinhard A; de Leval L; Huber GF; Pezier TF; Soltermann A; Giger R; Arnold A; Dettmer M; Arnoux A; Müller M; Spreitzer S; Lang F; Lutchmaya M; Stauffer E; Espeli V; Martucci F; Bongiovanni M; Foerbs D; Jochum W
Head Neck; 2017 Oct; 39(10):2004-2015. PubMed ID: 28691255
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma.
Lim MY; Dahlstrom KR; Sturgis EM; Li G
Head Neck; 2016 Aug; 38(8):1139-44. PubMed ID: 27002307
[TBL] [Abstract][Full Text] [Related]
3. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
[TBL] [Abstract][Full Text] [Related]
4. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
5. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
[TBL] [Abstract][Full Text] [Related]
6. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
7. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
8. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
Swartz JE; Pothen AJ; van Kempen PM; Stegeman I; Formsma FK; Cann EM; Willems SM; Grolman W
Head Neck; 2016 Sep; 38(9):1338-46. PubMed ID: 27027530
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
11. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
[TBL] [Abstract][Full Text] [Related]
13. Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
Head Neck; 2014 Mar; 36(3):323-7. PubMed ID: 23729374
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.
Lin BM; Wang H; D'Souza G; Zhang Z; Fakhry C; Joseph AW; Drake VE; Sanguineti G; Westra WH; Pai SI
Cancer; 2013 Oct; 119(19):3462-71. PubMed ID: 23861037
[TBL] [Abstract][Full Text] [Related]
15. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus genotype and oropharynx cancer survival in the United States of America.
Goodman MT; Saraiya M; Thompson TD; Steinau M; Hernandez BY; Lynch CF; Lyu CW; Wilkinson EJ; Tucker T; Copeland G; Peters ES; Altekruse S; Unger ER
Eur J Cancer; 2015 Dec; 51(18):2759-67. PubMed ID: 26602016
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
Wuerdemann N; Wittekindt C; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wagner S
Oncol Res Treat; 2017; 40(6):320-327. PubMed ID: 28558385
[TBL] [Abstract][Full Text] [Related]
18. Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer.
Matsumoto F; Fujimaki M; Ohba S; Kojima M; Yokoyama J; Ikeda K
Head Neck; 2015 Jul; 37(7):977-81. PubMed ID: 24700733
[TBL] [Abstract][Full Text] [Related]
19. Human papilloma virus status evaluation and survival description in selected oropharyngeal and laryngeal squamous cell carcinoma patients from Hungary.
Reka Fejer E; Abram Z; Zs Egyed J; Voidazan S; Toth E; Szentirmay Z; Kasler M
J BUON; 2016; 21(1):168-74. PubMed ID: 27061545
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
